At Waters, we have a long history of working alongside the scientific community in times of need through collaboration. The Innovation Response Team was created in March 2020 as a response to the COVID-19 pandemic.
In the early stages of the pandemic, we knew we wanted to offer an unprecedented amount of support, not just for our customers, but the global scientific community at-large. And, we wanted to be inclusive in our work, our mission, and the global scientific networks in which we operate. We’ve worked with non-profits, academics, start-ups and corporations, each with their own unique perspectives on how to quickly and effectively deliver diagnostics, therapies and vaccines.
Today, as the world continues to battle COVID-19, that collaborative approach is more important than ever. Ultimately, this challenge is far too great for any organization to tackle alone. But, with those challenges comes opportunity.
The scientific community can demonstrate to the world how, through inclusion and collaboration, we are stronger together. At Waters, that mindset has sustained us for over 60 years, and it will continue to, as we fight COVID-19 and whatever comes next.
Some members of the Innovation Response Team at the Innovations Summit Gala 2019
See the stories behind the experts who make up the Innovation Response Team and learn how we are helping to fight COVID-19 through observations with mass spectrometry, and glycan and oligonucleotide characterization.
